Target intelligence / Profile preview

Bacterial azoreductase

Molecular classification
Enzyme, Oxidoreductase, Flavoprotein
01

Overview

Bacterial azoreductase is a class of flavin mononucleotide (FMN)-dependent oxidoreductase enzymes found widely in bacteria. These enzymes catalyze the reductive cleavage of azo bonds (−N=N−), using NADH or NADPH as electron donors, to degrade azo dyes and activate or deactivate azo prodrugs. Structurally, azoreductases such as AzoR and AzoA have a flavodoxin-like fold and assemble as homodimers, each with an FMN binding site[1][2][3]. Azoreductases are important in the bioremediation of industrial dyes, metabolism of certain food additives, and activation or deactivation of pharmaceuticals with azo linkages (such as sulfasalazine), particularly in the gut microbiome[5]. The substrate specificity of bacterial azoreductases varies, but they generally show broad activity against a range of azo compounds[3]. These enzymes can be exploited in biotechnological applications, such as wastewater treatment and prodrug design, but also pose safety concerns due to the possible production of toxic aromatic amines as byproducts of azo bond reduction.

Other names
Azoreductaseazo reductaseNAD(P)H-dependent azoreductaseFMN-azoreductaseAzoAAzoRBVU5
02

Mechanism of action

Catalyzes the reductive cleavage of azo (-N=N-) bonds in dyes and prodrugs, using NAD(P)H as the electron donor to produce colorless aromatic amines[1][2][3][5].

03

Biological functions

Reductive cleavage of azo bondsDegradation of azo dyesDetoxification of xenobioticsProdrug activation (for some therapeutic agents)
04

Disease associations

Infection (relevant to the gut microbiome and potential microbial translocation)Other (biodegradation and metabolism of xenobiotics—environmental and pharmaceutical relevance)
05

Safety considerations

Formation of potentially toxic aromatic amines as cleavage productsVariability in enzyme activity among bacterial species and individuals (impacts prodrug activation, xenobiotic metabolism)
06

Interacting drugs

Azo dye-based drugs (e.g. sulfasalazine, olsalazine, balsalazide) which require reductive cleavage for activation

Beyond the preview

Go deeper on Bacterial azoreductase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial azoreductase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call